- Tips for Spending Holiday Time With Family Members Who Live with Dementia
- Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
- Check Your Pantry, Lay’s Classic Potato Chips Recalled Due to Milk Allergy Risk
- Norovirus Sickens Hundreds on Three Cruise Ships: CDC
- Not Just Blabber: What Baby’s First Vocalizations and Coos Can Tell Us
- What’s the Link Between Memory Problems and Sexism?
- Supreme Court to Decide on South Carolina’s Bid to Cut Funding for Planned Parenthood
- Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says
- A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful
- Some Abortion Pill Users Surprised By Pain, Study Says
Gene Variant May Double Alzheimer’s Risk for Women: Study
Having a copy of a certain gene variant increases women’s risk for Alzheimer’s disease much more than it does for men, a new study indicates.
Stanford University researchers analyzed data from more than 8,000 people, most older than 60, who were tracked over a long period of time at about 30 Alzheimer’s centers across the United States.
Overall, having a copy of the ApoE4 gene variant increased the risk of Alzheimer’s. But further analysis showed that women with a copy of this gene variant were about twice as likely to develop Alzheimer’s as those who did not have the variant. Men with the ApoE4 variant had only a slightly increased risk of developing Alzheimer’s, according to the study in the April 14 issue of the Annals of Neurology.
The findings could help improve understanding of the underlying causes of Alzheimer’s disease, according to senior study author Dr. Michael Greicius. He’s an assistant professor of neurology and neurological sciences, and medical director of the Stanford Center for Memory Disorders.
Greicius noted that women are much more likely than men to develop Alzheimer’s, and that this difference is only partly due to the fact that women tend to live longer than men.
“Even after correcting for age, women appear to be at greater risk,” Greicius said in a Stanford news release.
The findings also suggest that doctors need to take different approaches when dealing with women and men.
“These days, a lot of people are getting genotyped [genetic testing] either in the clinic or commercially. People come to me and say, ‘I have an ApoE4 gene, what should I do?’ If that person is a man, I would tell him that his risk is not increased much if at all. If it’s a woman, my advice will be different,” Greicius said.
Between 5 million and 6 million Americans have Alzheimer’s, and that number could more than double by mid-century, according to experts.
More information
The U.S. National Institute of Neurological Disorders and Stroke has more about Alzheimer’s disease.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.